Showing results (11-20 of 100) with videos related to
Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|January 4, 2007
Ectopic fat accumulation and metabolic syndromeNeda Rasouli, Behzad Molavi, Steven C Elbein, et al.Journal of Diabetes and Its Complications|September 19, 2020
Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonistsMadison Petri, Inderpreet Singh, Chelsea Baker, et al.Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition|December 30, 2011
Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapyElisa Hsia, Stacey A Seggelke, Joanna Gibbs, et al.American Journal of Physiology. Endocrinology and Metabolism|September 14, 2006
Effects of pioglitazone and metformin on beta-cell function in nondiabetic subjects at high risk for type 2 diabetesNeda Rasouli, Philip A Kern, E Albert Reece, et al.The Journal of Biological Chemistry|September 2, 2004
Divergent effects of peroxisome proliferator-activated receptor gamma agonists and tumor necrosis factor alpha on adipocyte ApoE expressionLili Yue, Neda Rasouli, Gouri Ranganathan, et al.The Journal of Clinical Endocrinology and Metabolism|September 20, 2007
Impact of family history of diabetes and ethnicity on -cell function in obese, glucose-tolerant individualsNeda Rasouli, Horace J Spencer, Amir Adel Rashidi, et al.Journal of Diabetes Science and Technology|May 13, 2016
Endocrinology Telehealth Consultation Improved Glycemic Control Similar to Face-to-Face Visits in VeteransWinnie Liu, David R Saxon, Bryan McNair, et al.Therapeutic Advances in Endocrinology and Metabolism|November 2, 2023
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitusSteven Rella, Joseph Onyiah, Chelsea Baker, et al.Therapeutic Advances in Endocrinology and Metabolism|January 25, 2021
Should metformin remain the first-line therapy for treatment of type 2 diabetes?Chelsea Baker, Cimmaron Retzik-Stahr, Vatsala Singh, et al.Life Sciences|February 1, 2019
Hyperoxia improves carbohydrate metabolism by browning of white adipocytes in obese type 2 diabetic ratsReza Norouzirad, Mahboubeh Ghanbari, Zahra Bahadoran, et al.Pageof 10